Previous Article | Next Article 
Journal of Virology, November 2000, p. 10430-10437, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Hepatitis C Virus Internal Ribosome Entry Site (IRES) Stem
Loop IIId Contains a Phylogenetically Conserved GGG Triplet
Essential for Translation and IRES Folding
Ronald
Jubin,1
Nicole E.
Vantuno,1
Jeffrey S.
Kieft,2
Michael G.
Murray,1
Jennifer A.
Doudna,2,3
Johnson Y. N.
Lau,1 and
Bahige M.
Baroudy1,*
Department of Antiviral Therapy,
Schering-Plough Research Institute, Kenilworth, New Jersey
07033,1 and Department of Molecular
Biophysics and Biochemistry3 and Howard
Hughes Medical Institute,2 Yale University,
New Haven, Connecticut 06520
Received 27 March 2000/Accepted 18 August 2000
 |
ABSTRACT |
The hepatitis C virus (HCV) internal ribosome entry site
(IRES) is a highly structured RNA element that directs
cap-independent translation of the viral polyprotein. Morpholino
antisense oligonucleotides directed towards stem loop
IIId drastically reduced HCV IRES activity. Mutagenesis studies of this
region showed that the GGG triplet (nucleotides 266 through 268) of the hexanucleotide apical loop of stem loop IIId is
essential for IRES activity both in vitro and in vivo. Sequence
comparison showed that apical loop nucleotides (UUGGGU) were absolutely
conserved across HCV genotypes and the GGG triplet was strongly
conserved among related Flavivirus and Pestivirus nontranslated regions. Chimeric IRES elements
with IIId derived from GB virus B (GBV-B) in the context of the HCV IRES possess translational activity. Mutations within the IIId stem
loop that abolish IRES activity also affect the RNA structure in RNase
T1-probing studies, demonstrating the importance of correct RNA folding to IRES function.
 |
INTRODUCTION |
Hepatitis C virus (HCV)
is a member of the genus Hepacivirus in the
Flaviviridae family (8). HCV infection is a
global health problem, with chronically infected patients exhibiting an
increased risk for the development of cirrhosis and hepatocellular carcinoma (19). HCV has a single-strand, positive-sense RNA genome known for its genetic heterogeneity, and HCV has been
classified into six major genotypes and a series of
subtypes (30, 31). However, the 5' nontranslated
region (5'NTR) of the virus is relatively well conserved among all
genotypes (5, 9).
Located within the 5'NTR is the internal ribosome entry site (IRES)
previously shown to contain sequence and structural elements responsible for directing cap-independent translation of the viral polyprotein (36, 38). Stem-loop I had been
previously shown not to be essential for IRES activity (17, 27,
28). Based on a number of published reports, the minimal sequence
required for IRES activity is believed to include nucleotide sequences spanning nucleotides (nt) 42 through 356 (12-14, 26-28).
Within the minimal IRES sequence, three primary structured domains,
known as stem-loops II, III, and IV, have been identified based on
chemical and enzymatic probing as well as phylogenetic comparisons
(4, 13, 14, 20, 40). Each primary domain of the IRES is
further defined based on a combination of double-stranded (ds) helices and single-strand bulges or loops. A number of studies have been conducted to determine the importance of some of these structured elements in viral translation, including the pseudoknot and stem-loops II, IIIb, IIIc, IIIe, and IV (12-14, 17, 25, 27-29, 35, 39, 40). In general, mutations altering double-stranded helical regions can have deleterious effects on translation. However, when
compensatory mutations are made to restore Watson-Crick base pairing,
the translation efficiency can often be restored. In contrast,
mutational changes in loop regions appear to be more amenable and may
retain IRES activity (39). Recently, it has also been
demonstrated that domains IIIb to IIIc are involved in the binding to
eukaryotic initiation factor 3a and the 40S ribosomal subunit (6,
23, 32). These studies suggested that the HCV IRES contains
sequence- and structure-specific elements that are essential for IRES activity.
Domain III of the HCV IRES has six distinct regions containing
stem-loop structures (a through f) according to previously proposed
secondary-structure models (4, 13). Stem-loop IIId is a
highly conserved region of domain III spanning nucleotides 253 through
279. It is composed of two double-stranded helical (1 and 2) elements
separated by a 3-nucleotide internal asymmetric loop with a
6-nucleotide hairpin loop at the distal end of double-stranded helix 2 (Fig. 1C). Large deletions of HCV IRES
sequences including stem-loop IIId have been previously shown to be
detrimental to IRES function (12, 28).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Schematic representation of plasmid used for
analysis containing the HCV IRES. T7 is the location of the T7 RNA
polymerase promoter sequences for transcription of bicistronic RNA.
Reporter RLUC is under translational control of the Xenopus
-globin 5'NTR while Core (hashed box)/FLUC is under translational
control of the HCV IRES as described in Materials and Methods. (B)
Morpholino antisense oligonucleotides used for antisense inhibition
studies. Antisense nucleotide sequences are listed in underlined text
within each set, while mismatch controls are listed below. Dots
represent identical sequences, while lowercase letters denote base pair
substitutions. m(4) denotes a 4-bp mismatch, and RDM indicates random
sequences. (C) Secondary model of the HCV IRES (15),
including all sequences (nucleotides 1 through 408) used to construct
the assay plasmid shown in panel A. Locations of the antisense targets
are shown with oval boxes. IIId loop nucleotides 253 through 279 and
numbers corresponding to antisense target sequences are shown in bold
type.
|
|
The aim of the present study was to examine the specific role of
stem-loop IIId in HCV IRES translation by a combination of techniques
including antisense studies, mutagenesis, and the assembly of chimeric
IRESs. RNase T1 protection assays were subsequently conducted to probe the structural changes induced by point mutations and chimeric IRES elements.
 |
MATERIALS AND METHODS |
Plasmids.
The HCV IRES element derived from genotype 1b was
obtained from plasmid pK1b (kindly provided by A. Nomoto). To
facilitate cloning, plasmid pK1bE was constructed by modifying the
sequences preceding the IRES element through the annealing of two
partially complementary synthetic oligonucleotides (S-ONs) (Life
Technologies, Gaithersburg, Md.) (5'-GCGCCAGCCCC-3' and
5'-GGGCTGGCGC-3') introduced into the XbaI-Klenow
and XcmI restriction sites. This allowed for the
introduction of an EheI restriction site at nucleotide 1 of
the HCV IRES. A similar approach was adopted for the modification of
the core sequences using two partially complementary oligonucleotides (5'-CGGCGCCACGT-3' and 5'-GGCGCCGACGT-3') into
the AatII restriction site. Again this created an
EheI restriction site. Hence, an EheI cassette
plasmid (pK1BE/E) containing HCV nucleotides 1 through 408 with three
additional nucleotides at the 3' end (GGC) was established.
Stem loop IIId mutants were constructed by insertion of annealed S-ONs
containing mutations into the
NheI and
StuI
restriction
sites that span the stem loop. Plasmid DNA was purified
using
Maxiprep kits (Qiagen, Valencia, Calif.), and all sequences were
confirmed by restriction analysis and primer extension automated
DNA
sequencing (ABI PRISM 377 DNA sequencer; Perkin-Elmer, Norwalk,
Conn.).
Bicistronic plasmids were constructed to determine HCV IRES activity in
relation to cap-dependent translation. Bicistronic
constructs were
generated by first assembling a cassette vector
containing the
Renilla (
RLUC) and firefly (
FLUC)
luciferase genes
as cistrons 1 and 2, respectively. Plasmid
pGL3-control (Promega,
Madison, Wis.) containing
FLUC was
modified to remove the initiator
codon AUG and introduce an
SnaBI restriction site at its 5' terminus.
Two S-ONs,
5'-AGCTTACGTAGAAGACGCCAAAAACATAAAGAAAGGCCCGGC-3' and
5'-GCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCTACGTA-3', were annealed
and
introduced into
HindIII and
EheI
restriction sites. This insertion
replaces the initiator
methionine codon with a valine codon (pGL3CHV).
The
XbaI
restriction site in the vector sequence was eliminated
to simplify
additional cloning steps by restricting pGL3CHV with
XbaI-Klenow and religating [pGL3CHV(-X)]. Plasmid pT7

RL
containing
the T7 promoter,
Xenopus 
-globin 5'NTR, and
the
RLUC gene was
restricted with
SmaI-
SnaBI and religated to delete the
SnaBI restriction
site [pT7

RL(-s/s)] (
16).
The bicistronic cassette vector containing
the
RLUC gene 5'
of the
FLUC gene was constructed by cloning the
HindIII/
BamHI-Klenow-treated fragment of
pGL3CHV(-X), which contains
the
FLUC gene, simian virus 40 poly(A) signal, and enhancer sequences,
into pT7

RL(-s/s) restricted
with
XbaI-Klenow resulting in pT7

R-P(a).
HCV IRES
sequences were isolated from pK1BE/E by restriction digestion
with
EheI and annealed in frame with the
FLUC gene of
pT7

R-P(a)
restricted with
XbaI-Klenow and
SnaBI, creating pT7

R(1b/408)P.
This plasmid was used for
simultaneous monitoring of cap-dependent
and IRES-mediated translation
(Figure
1A). Stem-loop IIId mutations
were transferred into the
bicistronic plasmid by swapping the
NcoI-
AccI
fragments from the monocistronic plasmids into the same
restriction
sites in pT7

R(1b/408)P.
An encephalomyocarditis viral (EMCV) bicistronic plasmid was prepared
to serve as an HCV IRES specificity control in antisense
studies.
pCITE-4a (Novagen, Milwaukee, Wis.), a vector containing
an EMCV IRES,
was modified by inserting two annealed S-ONs,
5'-TAGAAGACGCCAAAAACATAAAGAAAGGCCCGGCGCC-3'
and
5'-GGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCTA-3', into the
MscI
restriction site, which contained sequences that
overlapped the
3' portion of the EMCV IRES and the 5' end of the
FLUC gene. The
resulting plasmid pCITE-4a

LUC(E)
facilitated cloning the EMCV
IRES in frame with the
FLUC
gene. pT7BR(EMCV)P was created by
cloning the 543-bp
BsaWI-
EheI fragment containing the EMCV IRES
into
pT7BR-P(a) restricted with
XbaI-Klenow and
EheI.
In vitro transcription and translation.
In vitro
transcription and translation reactions were carried out using the TNT
coupled transcription-translation system (Promega, Madison, Wis.).
Duplicate reaction mixtures (25 µl) were assembled containing 19.5 µl of rabbit reticulocyte lysate (RRL) master mixture and 0.5 µl of
methionine (1 mM) and were programmed with 5.0 µl of purified plasmid
DNA (0.1 µg/µl) in Microlite 2 microtiter plates (Dynex, Chantilly,
Va.). Following the combination of reaction mixture components, samples
were incubated at 30°C for 90 min. Postincubation, RRL reactions were
analyzed for both RLUC and FLUC reporter activities using the
Dual-Luciferase reporter assay system (Promega) according to the
manufacturer's instructions and quantitated with a luminometer (model
MLX; Dynex). The relative translational efficiency in
mutational-analysis experiments was determined by comparing FLUC/RLUC
ratios of mutation samples to native IRES reactions.
Antisense studies.
Translation reactions were carried out as
described above except that morpholino antisense oligonucleotides or
mismatch controls (AntiVirals, Corvallis, Oreg.) were added to a
50-µl reaction mixture (39 µl of RRL master mixture, 1.0 µl of
methionine, 5.0 µl of DNA, and 5.0 µl of 10× morpholino
oligonucleotide). Relative levels of IRES translational inhibition in
antisense studies were determined for each reporter independently, and
percent inhibition was determined by comparison of samples with
morpholino antisense oligonucleotides to control samples.
In vivo cell culture studies.
BT7-H cells that
constitutively express T7 polymerase were maintained in Dulbecco's
modified eagle medium (DMEM) containing 10% fetal calf serum, 100 U of
penicillin and streptomycin per ml, 5 ml of nonessential amino acids,
and 500 µg of G418 sulfate per ml (14). Cells were seeded
into 96-well tissue culture dishes at a density of 1.2 × 104 cells/well and incubated overnight at 37°C in 5%
CO2. DNA transfections were carried out in duplicate using
1.0 µl of plasmid DNA (0.1 µg) and Lipofectamine Plus transfection
reagents (Life Technologies) according to the manufacturer's protocol.
Cells were washed, and medium was replaced with a 60-µl mixture
containing 1.0 µl of DNA, 1.0 µl of Plus reagent, and 0.5 µl of
Lipofectamine in DMEM without supplements and incubated for 3 h at
37°C and 5% CO2. Following incubation, the medium was
removed by aspiration and replaced with complete medium and returned to
the incubator for an additional 18 h. Subsequently, the cells were
lysed in 25 µl of 1× passive lysis buffer and assayed using the
Dual-Luciferase assay system (Promega). Cell lysate (20 µl) was
transferred to Microlite 2 96-well plates and placed into the
luminometer. Luciferase activities were analyzed in a fashion identical
to that for in vitro samples except that luciferase substrate mixtures
were added by microinjection followed by reporter activity quantitation
as described above.
RNase T1 probing.
HCV IRES RNAs including
nucleotides 40 through 372 were transcribed from linearized plasmid
DNA, purified, and subjected to RNase T1 enzyme as
previously described (18). Briefly, 5'-end-labeled RNA was
heated to 65°C for 1 min and then cooled to room temperature. This
annealed RNA was added to a tube containing buffer (final concentration, 30 mM N-2-hydroxyethyl
piperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.5]), 1.0 µg of tRNA, and the desired divalent ion to a final volume of 9.0 µl. RNA was incubated at 37°C for 5 min to achieve folding
equilibrium. Cleavage was initiated by addition of 1.0 µl of RNase
T1 (0.1 U/µl; Boehringer Mannheim), incubated at 37°C
for 7 min, then quenched with the addition of 10.0 µl of 9 M urea-1
mM EDTA, and placed on ice. Reaction mixtures were resolved on 10%
polyacrylamide gels that were dried and visualized on a PhosphorImager.
 |
RESULTS |
RNase H-independent antisense oligonucleotides directed to
stem-loop IIId drastically reduce IRES activity.
Inhibition
studies of the HCV IRES IIId region were carried out using morpholino
antisense oligonucleotides which have been previously shown to work in
an RNase H-independent fashion (33, 34). Loss of translation
efficiency by hybridization arrest might indicate whether loop IIId
interactions are important for IRES function. As shown in Fig. 1B
and C, four separate sets of morpholino antisense
oligonucleotides spanning HCV nucleotides 260 through 279 (set 1), 330 through 354 (set 2A), 340 through 359 (set 2B), and 4 through 23 (control set) were synthesized. For each region targeted, two
additional control oligonucleotides were also synthesized that
contained either 4-bp mismatches or random rearrangement of the target
nucleotide sequences. Morpholino antisense oligonucleotides directed to
the region spanning the initiator AUG (sets 2A and 2B) showed dramatic
reduction of FLUC (IRES-mediated) activities (>80%) with low (<22%)
inhibition of the upstream RLUC (cap control) activities (Fig.
2A). Set1A, which spans stem loop IIId,
exhibited inhibitory values comparable to sets 2A and 2B. Control set
oligonucleotides directed to sequences situated 5' of the minimal IRES
(nt 43 through 356) exhibited no inhibition of IRES activity.
Furthermore, the control morpholino antisense oligonucleotides for each
individual set (4-bp mismatch and random) showed no specific
inhibition of the HCV IRES. In addition, set 1 exhibited a
dose-dependent inhibition of the HCV IRES-mediated translation and
exerted no inhibitory effects on the translational efficiency of the
EMCV IRES (Fig. 2B), demonstrating that inhibition was HCV IRES
specific and did not affect reporter activities. Based on the specific
inhibition of IRES activity exhibited by set 1 and the absolute
sequence conservation of HCV nucleotides spanning 264 through 269, we
proceeded to carry out mutational analysis of this apical loop to
determine which nucleotides are essential for IRES activity.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Morpholino antisense inhibition of the HCV IRES. (A)
Equal concentrations (200 nM) of various antisense oligonucleotides
(see Fig. 1B) were included in coupled TNT transcription/translation
reactions programmed with pT7 R(1b/408)P. Percents inhibition were
determined by direct comparison of antisense oligonucleotide-containing
samples to control reaction samples without antisense addition.
Open bars represent FLUC (IRES) inhibition; shaded bars represent
RLUC inhibition. (B) HCVm260-279 antisense oligonucleotides were added
to TNT transcription-translation reactions at assay concentrations
ranging from 25 to 200 nM. Triangles represent pT7 R(1b/408)P;
squares represent pT7 R(EMCV)P. Open figures illustrate FLUC
(IRES) inhibition patterns;shaded figures represent RLUC
inhibition of each respective assay plasmid.
|
|
Dramatic changes in the apical loop of IIId severely reduce IRES
activity.
Mutational in vitro studies of the apical loop of IIId
were conducted, including sequence deletions, complements, and
inversions, to assess the requirements of this region for IRES
translational activities. As shown in Fig.
3, a mutation containing complete deletion of nucleotides spanning the apical loop (LD-SD) totally abolished IRES activity that demonstrated the importance of this loop
structure for translational activity. Two additional mutations that
maintained the loop structure, but created partial (LD-SM) or total
sequence complement (LC-SC) mutations produced similar results, which
suggested that primary sequence requirements were also important for
IRES function. Finally, a mutation containing the loop sequence in 3'
to 5' orientation (LC-SV) was analyzed, which produced moderate
activity (37%) of the IRES. Correspondingly, the activities of all
mutations were similar to the in vivo cell-based study results.
Therefore, in an effort to map IRES efficiency at the
individual-nucleotide level, a series of systematic point mutations were assembled for analysis in the bicistronic system.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Mutational analysis of the HCV IRES IIId apical loop.
(A) Specific IIId apical loop mutations and secondary structures.
Nucleotide substitutions are denoted by lowercase letters, with
wild-type (WT) IIId sequences and structures listed at the top for
comparison. Abbreviations: LD, loop deleted; LC, loop conserved; SD,
sequence deleted; SM, semimaintained; SC, sequence complementary; SV,
sequence varied 3' to 5'. (B) Wild-type bicistronic plasmid DNA or
plasmid DNA samples containing mutations were used to program in
vitro-coupled transcription-translation RRL reactions or were
transfected into BT7-H cells. Relative IRES efficiencies were
determined for each mutation by direct comparison of FLUC/RLUC ratios
to wild-type values (arbitrarily 100%). Open bars represent in vitro
RRL mean IRES efficiencies; shaded bars represent the same from BT7-H
cell-based transfections. Duplicate samples were analyzed in three
separate experiments; error bars represent standard errors of the
mean.
|
|
Point mutations of the apical loop produce various levels of
inhibition of HCV IRES.
Single-nucleotide mutations with
complementary-nucleotide substitutions were systematically introduced
into the IIId apical loop nucleotides (spanning nucleotides 264 through
269 [Fig. 4A]) and analyzed in the
bicistronic system. Translational activities of point mutations
exhibited varied levels of IRES translational efficiency. The U-A
complementary mutations (U264A, U265A, and U269A) exhibited strong
translational activities in RRL assays (75, 58, and 85%, respectively)
and, in the cell-based studies, they all showed similar translational
activities of ~43%, suggesting the necessity of these nucleotides in
the more stringent cell-based system. In contrast, all G-C
complementary mutations (G266C, G267C, and G268C) showed >95%
reduction in both RRL and in vivo cell-based assays (Fig. 4B).
Concurrently, a set of G-C mutations containing multiple substitutions
was also analyzed, which displayed results similar to those with single
substitutions (Fig. 4C and D). Similar results were confirmed in
monocistronic assays comparing HCV core expression and also in RNA
bicistronic translation assays (reference 18 and
data not shown). These data indicated that U nucleotides in the IIId
apical loop are important for optimal IRES function and that each G
nucleotide was absolutely essential for IRES translation.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Mapping of IIId nucleotides essential for IRES
translation. (A and C) Specific IIId apical loop mutations and
secondary structures. Nucleotide substitutions are denoted by lowercase
letters, with wild-type (WT) IIId sequences and structures listed at
the top for comparison. (B and D) Relative IRES translational
efficiencies of point or multiple G mutations, respectively, were
determined as described in the legend to Fig. 3. Open bars, in vitro
RRL mean IRES efficiencies; shaded bars, the same from BT7-H cell-based
transfections.
|
|
Sequence alignment of stem-loop IIId shows that the GGG triplet is
conserved among HCV genotypes and related viruses.
Secondary-structure predictions of Flavivirus and
Pestivirus have previously shown that the IIId stem-loop is
present in several related viral IRES elements (20). To
determine whether these IIId loops also contained conserved sequences
similar to those of HCV, an alignment analysis was conducted with
several related viruses. First, several HCV isolates, one from each of
the six genotypes of HCV, were aligned to the HCV 1b IIId sequences
used in this present study (Fig. 5). The
UUGGGU sequences comprising the entire apical loop are
absolutely conserved among all genotypes listed, and the majority of
the double-stranded helix and internal asymmetric loop sequences are
also highly conserved except for a double covariant substitution, U262C
and C270U. Further alignments pairing the GGG triplet of the IIId
region with the related GB virus B (GBV-B) Flavivirus shows
the UUGGG sequences are conserved, however secondary structure models
predict that the UU pair is absent from the apical loop
(14). The pestiviruses, bovine viral diarrhea virus (BVDV)
and classical swine fever virus (CSFV) were also aligned and showed
conservation of the GGG triplet and GGGU sequences, respectively. Based
on these alignment profiles and previously predicted secondary
structures, it is apparent that apical loop IIId is conserved among
related viruses with the GGG triplet being absolutely conserved.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
IIId stem-loop sequence alignment of HCV genotypes 1 through 6, related Flavivirus GBV-B, and pestiviruses BVDV
and CSFV. Nucleotide numbers in viral genomes are listed along with
genotype and accession number (GenBank). HCV IRES genotype 1b used in
this study is underlined at the top, with the conserved GGG triplet
identified by asterisks. Listed below genotype 1b are the sequence
alignments. Identical sequences are represented by dots, and nucleotide
variations are indicated by lowercase letters, while dashes denote gaps
in alignments.
|
|
These sequence and mutational data strongly support the critical
requirements of nucleotides G266, G267, and G268 for HCV
IRES activity,
thus suggesting the possibility of a similar importance
in related
viruses. To test this hypothesis, chimeric IRES elements
were assembled
containing substitution of the HCV IIId region
with those of GBV-B, a
related virus, and the HIV-1 Tar element,
an unrelated viral NTR region
containing a GGG triplet in an apical
loop (
15).
Chimeric HCV IRESs containing a GBV-B IIId can support IRES
activity.
A chimeric IRES that contained a major portion of the
GBV-B stem-loop IIId was introduced into the NheI and
StuI sites of the HCV IRES (Fig.
6A). Comparison of the chimeric
HCV/IIId-GBV-B (GBV-B1) chimera with the native bicistronic construct
exhibited an in vitro activity of 32% (Fig. 6B). Two additional
mutations were subsequently constructed that incorporated structural
features unique to the HCV IRES into the GBV-B stem-loop in attempts to improve translation. First, the internal asymmetric loop of HCV IIId
was introduced into the GBV-B sequence (GBV-B2). Second, the UU pair
(HCV nt 264 through 265) was added preceding the GGG triplet, thus
creating an identical HCV apical loop with a GBV-B ds helix (GBV-B3)
(Fig. 6A). Unexpectedly, introduction of the internal asymmetric loop
completely abolished IRES activity. In contrast, removal of the
internal asymmetric loop from wild-type HCV IIId resulted in a dramatic
loss of IRES activity (data not shown). The addition of the UU
moderately enhanced activity (32 to 43%) in the in vitro studies (Fig.
6B). Levels of the two active GBV-B chimeras (B1 and B3) showed similar
in vivo results (~18%). We also constructed and analyzed in parallel
a human immunodeficiency virus type 1 (HIV-1) Tar loop chimera that
possesses a secondary structure similar to HCV IIId and also contains a
GGG in its apical loop (Fig. 6A). IRES activity was severely limited
(<10%) in either the in vitro or in vivo cell-based assays with the
HCV/Tar-HIV-1 chimera (Fig. 6B).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 6.
Chimeric substitutions and effects on relative IRES
translation. (A) Specific IIId apical loop mutations and secondary
structures. Nucleotide substitutions are denoted by lowercase letters,
with wild-type (WT) IIId sequences and structures listed at the top for
comparison. (B) Relative IRES translational efficiencies of chimeric
IRESs were determined as described in the legend to Fig. 3. Open bars
represent in vitro RRL mean IRES efficiencies; shaded bars represent
the same from BT7-H cell-based transfections.
|
|
Structural analysis of chimeric mutants.
Enzymatic probing
with RNase T1 has been previously employed to monitor the
ion-dependent folding of the HCV IRES (18). We used this
technique to determine the changes in RNA structure that accompany the
introduction of chimeric sequences into the HCV IRES. Figure
7 shows the cleavage patterns of
wild-type HCV IRES RNA and the three GBV-B chimeras, in the absence and
presence of 2.5 mM magnesium. Both GBV-B1 and GBV-B3 have protection
patterns similar to that of the wild type in both the absence and
presence of the divalent ion (lanes 4, 5, 8, 9, 16, 17). The chimeras
differ only slightly from the wild type in that the apical loop GGG
sequence is cut somewhat more strongly in the absence of magnesium ion. In contrast, the translationally inactive GBV-B2 chimera has an RNase
T1 protection pattern that clearly differs from the wild type irrespective of ionic conditions (lanes 12 and 13). Specifically, positions G253 and G255 are cleaved strongly in the absence of magnesium, while G nucleotides both up- and downstream that are cut in
the wild-type sequence are protected in GBV-B2 (G258 through 267 and
G243 through 249). In the presence of magnesium, this pattern changes
dramatically. The G nucleotides in the apical loop are strongly cut,
but the G nucleotides upstream of this loop (G245 through G255) are now
susceptible to cleavage.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 7.
RNase T1 probing of wild-type HCV IRES and
GBV-B/HCV chimeric RNA in the absence ( ) and presence (+) of 2.5 mM
MgCl2. Addition of MgCl2 resulted in cleavage
patterns similar to wild-type HCV for GBV-B1 and GBV-B3 (lanes 5, 9, and 17) but different for GBV-B2 (lane 13). The location of the IIId
apical loop is indicated by an arrow, and the asterisks indicate
chimeric loops. A bracket indicates the region of GBV-B2 that was most
different from others. This region corresponded to loop IIId and
upstream regions extending to G243. Lanes 1, 2, and 3 contain an RNase
U2 sequencing ladder (denaturing conditions), an RNase
T1 sequencing ladder (denaturing conditions), and a
hydrolysis ladder, respectively. These samples were not all run on the
same gel; therefore, the run times differ slightly.
|
|
Probing of mutants U264A, U265A, and U269A by RNase T
1 did
not reveal any changes in the cleavage patterns of these sequences,
relative to wild-type IRES (data not shown). This indicated that
these
mutations did not induce a detectable change in the RNA
structure. The
effects of G-C mutations of apical loop nucleotides
266 through 268 on
the RNase T
1 protection pattern have been reported
elsewhere (
18).
 |
DISCUSSION |
Antisense oligonucleotides directed to the HCV IRES have been
previously employed to inhibit IRES activity (1, 7, 11, 21,
37). Most antisense approaches such as phosphorothioate chemistry
elicit the cellular enzyme RNase H to the double-stranded target region
and invoke enzymatic cleavage of the RNA substrate. Morpholino
oligonucleotides contain a six-member morpholino backbone in place of
the natural riboside moiety which is not recognized by RNase H (2,
34). The present study demonstrated that hybridization arrest of
translation with morpholino antisense oligonucleotides in an RRL in
vitro assay can be useful in identifying potentially important regions
of an IRES element located at a distance from the translational start
site. Specifically, these data showed that translational inhibition as
a result of blocking IIId was possibly a result of IRES destabilization
or that it prevented essential RNA-protein and/or RNA-RNA interactions.
Mutational analysis was subsequently used to determine whether specific
IIId nucleotide sequences were important for maintaining translational
efficiency of the HCV IRES. Overall, these results implied that both
the loop nucleotide sequence and local structure were important aspects
for maintaining IRES activity. Further definition of critical
nucleotides in the IIId apical loop was accomplished by complementary
single-nucleotide substitutions that showed an essential requirement
for each G nucleotide (266 through 268) (Fig. 4). Parallel studies with
multiple G substitutions produced similar results, suggesting that G-C
mutation inhibition profiles are not additive but instead that there is
a critical requirement of each individual G nucleotide for IRES
activity. In contrast, the U-A (nucleotides 264, 265, and 269)
mutations did not drastically impair IRES function.
Sequence profiles aligning the IIId loops of different HCV genotypes
and related GBV-B, BVDV, and CSFV showed that apical loop GGG
trinucleotide sequences are conserved among these different viral
IRESs. Recently it has been shown that loop sequences in domain II of
GBV-B and HCV are highly conserved (14). To ascertain whether conservation of apical loop sequences from these related viruses was attributable to comparable roles in translation, chimeric IRESs were assembled containing GBV-B IIId sequences (Fig. 6A). Although GBV-B IIId sequences can support HCV IRES translation in
vitro, both GBV-B1 and GBV-B3 translational activities were reduced by
approximately 50% in cell-based assays (Fig. 6B). These apparent
differences between in vitro and in vivo results were also observed in
U-A mutations described earlier and may indicate different stringencies
for each assay system or strict intracellular requirements for
translation that are absent in the RRL system.
Lack of total recovery of IRES activity in GBV-B chimeras could be due
to inherent differences, unique to each IRES, that developed
during viral evolution. For example, examination of IIId stem loop
sequences of HCV compared to those of GBV-B and related pestiviruses
shows distinct differences (Fig. 5; 20, 24,
32). GBV-B lacks the internal asymmetric loop whereas BVDV
and CSFV actually contain two IIId loops (IIId and IIId') with IIId
containing a symmetric bulge between helical regions. Even the apical
loops of each IRES IIId stem-loop contain a unique arrangement as
indicated by secondary-structure predictions. However, similar
functions of BVDV and CSFV IRESs are supported by recent reports that
have shown comparable requirements for translation initiation factors
compared to the HCV IRES (24, 32). Moreover, it also has
been recently shown that an HCV/BVDV chimeric virus that contains the
HCV IRES is capable of viral translation and replication
(10). Thus, nucleotide variations between these related viruses are likely attributable to covariant
substitutions throughout the entire IRES element of each
respective virus, with maintenance of the overall tertiary structure as
the critical factor. Nonetheless, the GGG trinucleotide sequences were
maintained in each of the IRESs examined, with conservation of these
sequences being critical for IRES activity in all the viral sequences
tested except the unrelated HIV-1 Tar element (Fig.
8).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 8.
Summary figure compiling IIId apical mutations and
chimeras with their relative IRES translational efficiencies compared
to wild-type HCV IRES. Annotations are the same as those listed in the
legend to Fig. 5, except that apical loop sequences are listed in bold
type. Percent IRES activity is shown on the right with results listed
as in vitro- and cell-based results. Single values denote the same
result in both in vitro- and cell-based assays.
|
|
The HIV-1 Tar loop is an important recognition site for viral and
cellular proteins which are required to facilitate transcriptional elongation of the HIV-1 genome (41). Recently, it has been
shown that the Tar loop, including the apical GGG triplet, is an
important element for the recognition of eukaryotic initiation factor 2 (3). The complete loss of function in an HCV/Tar-HIV-1
chimera would suggest that the HCV IIId loop does not perform a similar function in HCV translation. This is supported by earlier studies, which did not show interactions of IIId sequences with the 48S complex
(23).
Previously it has been shown that cap-independent translation of the
HCV IRES involves the direct recruitment of the 40S ribosomal subunit
and eukaryotic initiation factor 3 (6, 23, 32). In an
earlier study, we showed that single G-to-C mutations of the IIId
apical loop can affect RNA folding in distinct patterns, yet all of
these mutations result in complete loss of IRES function (18). This is due in part to an equal loss of affinity of
each G-to-C point mutant for the 40S-ribosomal subunit (J. S. Kieft, K. Zhou, R. Jubin, and J. A. Doudna, submitted for publication). In
addition, the correct secondary structure of IIId has also been
suggested to be important for the binding of ribosomal protein S9
(22). IIId sequences and secondary structures are emerging as important factors for proper HCV IRES translation.
RNase T1 probing of various IRES constructs was used to
detect changes in the secondary structure and possibly the tertiary structure that are induced by the introduction of mutations or chimeric
sequences. The tendency for GBV-B2 to form alternate secondary
structures is likely due to the presence of the internal asymmetric
loop in the helical stem which could disrupt proper base pairing within
the stem loop. The addition of magnesium changes the pattern of RNase
T1 cleavage of GBV-B2, but it does not restore wild-type
folding (Fig. 7). Interestingly, the RNase T1 cleavage pattern in the presence of magnesium indicates that the apical loop of
IIId is forming, because the G nucleotides in the loop have become
sensitive to cleavage. However, nucleotides upstream of IIId continue
to be cleaved. It is possible that formation of this fold induces
specific local tertiary structures that in turn lead to rearrangement
of the secondary structure into a "more wild- type" structure. The
rearrangement of secondary structures by tertiary-structure formation
has been previously observed in other RNAs (42).
This study identified the IIId apical loop of the HCV IRES as an
important region for IRES translation. Mutagenesis specifically identified the GGG (nucleotides 266 through 268) triplet of IIId as the
region most critical for IRES function. The strong sequence conservation of this GGG triplet and chimeric HCV/IIId-GBV-B IRES activity suggests that a likely scenario exists among related flaviviruses and pestiviruses too. RNase T1-probing results
showed that the stem-loop IIId nucleotide sequence and local secondary structure can play a larger role in the correct folding of other regions of domain III that also contribute to proper IRES translation. In conclusion, the essentiality of IIId for translational activity and
IRES folding strongly supports its validity as a specific target for
the development of antiviral therapy.
 |
ACKNOWLEDGMENTS |
We are grateful to S. M. Lemon for the generous gift of the
BT7-H cell line and helpful suggestions during our studies. We also
thank M. Endres for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Antiviral
Therapy K-15-4945, Schering-Plough Research Institute, 2015 Galloping
Hill Rd., Kenilworth, NJ 07033. Phone: (908) 740-3046. Fax: (908)
740-3918. E-mail: bahige.baroudy{at}spcorp.com.
 |
REFERENCES |
| 1.
|
Alt, M.,
R. Renz,
P. H. Hofschneider,
G. Paumgartner, and W. H. Caselmann.
1995.
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Hepatology
22:707-717[CrossRef][Medline].
|
| 2.
|
Antivirals, Inc.
1997.
Technical bulletin no. 2.
Antivirals, Inc., Corvallis, Oreg.
|
| 3.
|
Ben-Asouli, Y.,
Y. Banai,
H. Hauser, and R. Kaempfer.
2000.
Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.
Nucleic Acids Res.
28:1011-1018[Abstract/Free Full Text].
|
| 4.
|
Brown, E. A.,
H. Zhang,
L. H. Ping, and S. M. Lemon.
1992.
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.
Nucleic Acids Res.
20:5041-5045[Abstract/Free Full Text].
|
| 5.
|
Bukh, J.,
R. H. Purcell, and R. H. Miller.
1992.
Sequence analysis of the 5' noncoding region of hepatitis C virus.
Proc. Natl. Acad. Sci. USA
89:4942-4946[Abstract/Free Full Text].
|
| 6.
|
Buratti, E.,
S. Tisminetzky,
M. Zotti, and F. E. Baralle.
1998.
Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3.
Nucleic Acids Res.
26:3179-3187[Abstract/Free Full Text].
|
| 7.
|
Caselmann, W. H.,
S. Eisenhardt, and M. Alt.
1997.
Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.
Intervirology
40:394-399[Medline].
|
| 8.
|
Choo, Q. L.,
G. Kuo,
A. J. Weiner,
L. R. Overby,
D. W. Bradley, and M. Houghton.
1989.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
Science
244:359-362[Abstract/Free Full Text].
|
| 9.
|
Davidson, F.,
P. Simmonds,
J. C. Ferguson,
L. M. Jarvis,
B. C. Dow,
E. A. Follett,
C. R. Seed,
T. Krusius,
C. Lin,
G. A. Medgyesi, et al.
1995.
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.
J. Gen. Virol.
76:1197-1204[Abstract/Free Full Text].
|
| 10.
|
Frolov, I.,
M. S. McBride, and C. M. Rice.
1998.
cis-acting RNA elements required for replication of bovine viral diarrhea virus-hepatitis C virus 5' nontranslated region chimeras.
RNA
11:1418-1435.
|
| 11.
|
Hanecak, R.,
V. Brown-Driver,
M. C. Fox,
R. F. Azad,
S. Furusako,
C. Nozaki,
C. Ford,
H. Sasmor, and K. P. Anderson.
1996.
Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
J. Virol.
70:5203-5212[Abstract/Free Full Text].
|
| 12.
|
Honda, M.,
L. H. Ping,
R. C. Rijnbrand,
E. Amphlett,
B. Clarke,
D. Rowlands, and S. M. Lemon.
1996.
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.
Virology
222:31-42[CrossRef][Medline].
|
| 13.
|
Honda, M.,
E. A. Brown, and S. M. Lemon.
1996.
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA.
RNA
2:955-968[Abstract].
|
| 14.
|
Honda, M.,
M. R. Beard,
L. H. Ping, and S. M. Lemon.
1999.
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation.
J. Virol.
73:1165-1174[Abstract/Free Full Text].
|
| 15.
|
Jaeger, J. A., and I. Tinoco, Jr.
1993.
An NMR study of the HIV-1 TAR element hairpin.
Biochemistry
32:12522-12530[CrossRef][Medline].
|
| 16.
|
Jubin, R., and M. G. Murray.
1998.
Activity screening of bacteria containing Renilla luciferase plasmids.
BioTechniques
24:185-188[Medline].
|
| 17.
|
Kamoshita, N.,
K. Tsukiyama-Kohara,
M. Kohara, and A. Nomoto.
1997.
Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors.
Virology
233:9-18[CrossRef][Medline].
|
| 18.
|
Kieft, J. S.,
K. Zhou,
R. Jubin,
M. G. Murray,
J. Y. Lau, and J. A. Doudna.
1999.
The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold.
J. Mol. Biol.
292:513-529[CrossRef][Medline].
|
| 19.
|
Kiyosawa, K.,
T. Sodeyama,
E. Tanaka,
Y. Gibo,
K. Yoshizawa,
Y. Nakano,
S. Furuta,
Y. Akahane,
K. Nishioka,
R. H. Purcell, et al.
1990.
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis virus.
Hepatology
4:671-675.
|
| 20.
|
Lemon, S. M., and M. Honda.
1997.
Internal ribosomal entry sites within the RNA genomes of hepatitis C virus and other flaviviruses.
Semin. Virol.
8:274-288[CrossRef].
|
| 21.
|
Mizutani, T.,
N. Kato,
M. Hirota,
K. Sugiyama,
A. Murakami, and K. Shimotohno.
1995.
Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
Biochem. Biophys. Res. Commun.
212:906-911[CrossRef][Medline].
|
| 22.
|
Odreman-Macchioli, F. E.,
S. G. Tisminetzky,
M. Zotti,
F. E. Baralle, and E. Buratti.
2000.
Influence of correct secondary and tertiary RNA folding on the binding of cellular factors to the HCV IRES.
Nucleic Acids Res.
28:875-885[Abstract/Free Full Text].
|
| 23.
|
Pestova, T. V.,
I. N. Shatsky,
S. P. Fletcher,
R. J. Jackson, and C. U. Hellen.
1998.
A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs.
Genes Dev.
12:67-83[Abstract/Free Full Text].
|
| 24.
|
Pestova, T. V., and C. U. Hellen.
1999.
Internal initiation of bovine diarrhea virus RNA.
Virology
258:249-256[CrossRef][Medline].
|
| 25.
|
Psaridi, L.,
U. Georgopoulou,
A. Varaklioti, and P. Mavromara.
1999.
Mutational analysis of a conserved tetraloop in the 5' untranslated region of hepatitis C virus identifies a novel RNA element essential for the internal ribosome entry site function.
FEBS Lett.
453:49-53[CrossRef][Medline].
|
| 26.
|
Reynolds, J. E.,
A. Kaminski,
H. J. Kettinen,
K. Grace,
B. E. Clarke,
A. R. Carroll,
D. J. Rowlands, and R. J. Jackson.
1995.
Unique features of internal initiation of hepatitis C virus RNA translation.
EMBO J.
14:6010-6020[Medline].
|
| 27.
|
Reynolds, J. E.,
A. Kaminski,
A. R. Carroll,
B. E. Clarke,
D. J. Rowlands, and R. J. Jackson.
1996.
Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon.
RNA
2:867-878[Abstract].
|
| 28.
|
Rijnbrand, R.,
P. Bredenbeek,
T. van der Straaten,
L. Whetter,
G. Inchauspe,
S. Lemon, and W. Spaan.
1995.
Almost the entire 5' non-translated region of hepatitis C virus is required for cap-independent translation.
FEBS Lett.
365:115-119[CrossRef][Medline].
|
| 29.
|
Rijnbrand, R. C.,
T. E. Abbink,
P. C. Haasnoot,
W. J. Spaan, and P. J. Bredenbeek.
1996.
The influence of AUG codons in the hepatitis C virus 5' nontranslated region on translation and mapping of the translation initiation window.
Virology
226:47-56[CrossRef][Medline].
|
| 30.
|
Simmonds, P.,
E. C. Holmes,
T. A. Cha,
S. W. Chan,
F. McOmish,
B. Irvine,
E. Beall,
P. L. Yap,
J. Kolberg, and M. S. Urdea.
1993.
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region.
J. Gen. Virol.
74:2391-2399[Abstract/Free Full Text].
|
| 31.
|
Simmonds, P.,
A. Alberti,
H. J. Alter,
F. Bonino,
D. W. Bradley,
C. Brechot,
J. T. Brouwer,
S. W. Chan,
K. Chayama,
D. S. Chen, et al.
1994.
A proposed system for the nomenclature of hepatitis C viral genotypes.
Hepatology
19:1321-1324[CrossRef][Medline].
|
| 32.
|
Sizova, D. V.,
V. G. Kolupaeva,
T. V. Pestova,
I. N. Shatsky, and C. U. Hellen.
1998.
Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs.
J. Virol.
72:4775-4782[Abstract/Free Full Text].
|
| 33.
|
Summerton, J.,
D. Stein,
S. B. Huang,
P. Matthews,
D. Weller, and M. Partridge.
1997.
Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.
Antisense Nucleic Acid Drug Dev.
7:63-70[Medline].
|
| 34.
|
Summerton, J., and D. Weller.
1997.
Morpholino antisense oligomers: design, preparation, and properties.
Antisense Nucleic Acid Drug Dev.
7:187-195[Medline].
|
| 35.
|
Tang, S.,
A. J. Collier, and R. M. Elliott.
1999.
Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5'UTR sequence.
J. Virol.
73:2359-2364[Abstract/Free Full Text].
|
| 36.
|
Tsukiyama-Kohara, K.,
N. Iizuka,
M. Kohara, and A. Nomoto.
1992.
Internal ribosome entry site within hepatitis C virus RNA.
J. Virol.
66:1476-1483[Abstract/Free Full Text].
|
| 37.
|
Wakita, T., and J. R. Wands.
1994.
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides: in vitro model for selection of target sequence.
J. Biol. Chem.
269:14205-14210[Abstract/Free Full Text].
|
| 38.
|
Wang, C.,
P. Sarnow, and A. Siddiqui.
1993.
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.
J. Virol.
67:3338-3344[Abstract/Free Full Text].
|
| 39.
|
Wang, C.,
P. Sarnow, and A. Siddiqui.
1994.
A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA.
J. Virol.
68:7301-7307[Abstract/Free Full Text].
|
| 40.
|
Wang, C.,
S. Y. Le,
N. Ali, and A. Siddiqui.
1995.
An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5' noncoding region.
RNA
1:526-537[Abstract].
|
| 41.
|
Wei, P.,
M. E. Garber,
S.-M. Fang,
W. H. Fischer, and K. A. Jones.
1998.
A novel CDK9-associated c-type cyclin interacts directly with HIV-1 tat and mediates its high-affinity, loop-specific binding to tar RNA.
Cell
92:451-462[CrossRef][Medline].
|
| 42.
|
Wu, M., and I. Tinico, Jr.
1998.
RNA folding causes secondary structure rearrangement.
Proc. Natl. Acad. Sci. USA
95:11555-11560[Abstract/Free Full Text].
|
Journal of Virology, November 2000, p. 10430-10437, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Barria, M. I., Gonzalez, A., Vera-Otarola, J., Leon, U., Vollrath, V., Marsac, D., Monasterio, O., Perez-Acle, T., Soza, A., Lopez-Lastra, M.
(2009). Analysis of natural variants of the hepatitis C virus internal ribosome entry site reveals that primary sequence plays a key role in cap-independent translation. Nucleic Acids Res
37: 957-971
[Abstract]
[Full Text]
-
Hellen, C. U. T., de Breyne, S.
(2007). A Distinct Group of Hepacivirus/Pestivirus-Like Internal Ribosomal Entry Sites in Members of Diverse Picornavirus Genera: Evidence for Modular Exchange of Functional Noncoding RNA Elements by Recombination. J. Virol.
81: 5850-5863
[Abstract]
[Full Text]
-
FERNANDEZ-MIRAGALL, O., RAMOS, R., RAMAJO, J., MARTINEZ-SALAS, E.
(2006). Evidence of reciprocal tertiary interactions between conserved motifs involved in organizing RNA structure essential for internal initiation of translation. RNA
12: 223-234
[Abstract]
[Full Text]
-
van den Born, E., Stein, D. A., Iversen, P. L., Snijder, E. J.
(2005). Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture. J. Gen. Virol.
86: 3081-3090
[Abstract]
[Full Text]
-
Rosenfeld, A. B., Racaniello, V. R.
(2005). Hepatitis C Virus Internal Ribosome Entry Site-Dependent Translation in Saccharomyces cerevisiae Is Independent of Polypyrimidine Tract-Binding Protein, Poly(rC)-Binding Protein 2, and La Protein. J. Virol.
79: 10126-10137
[Abstract]
[Full Text]
-
Kikuchi, K., Umehara, T., Fukuda, K., Kuno, A., Hasegawa, T., Nishikawa, S.
(2005). A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Res
33: 683-692
[Abstract]
[Full Text]
-
Neuman, B. W., Stein, D. A., Kroeker, A. D., Paulino, A. D., Moulton, H. M., Iversen, P. L., Buchmeier, M. J.
(2004). Antisense Morpholino-Oligomers Directed against the 5' End of the Genome Inhibit Coronavirus Proliferation and Growth{dagger}. J. Virol.
78: 5891-5899
[Abstract]
[Full Text]
-
Forton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., Thomas, H. C.
(2004). Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants. J. Virol.
78: 5170-5183
[Abstract]
[Full Text]
-
Michel, T., Martinand-Mari, C., Debart, F., Lebleu, B., Robbins, I., Vasseur, J.-J.
(2003). Cationic phosphoramidate {alpha}-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation. Nucleic Acids Res
31: 5282-5290
[Abstract]
[Full Text]
-
Lyons, A. J., Robertson, H. D.
(2003). Detection of tRNA-like Structure through RNase P Cleavage of Viral Internal Ribosome Entry Site RNAs Near the AUG Start Triplet. J. Biol. Chem.
278: 26844-26850
[Abstract]
[Full Text]
-
VYAS, J., ELIA, A., CLEMENS, M. J.
(2003). Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA
9: 858-870
[Abstract]
[Full Text]
-
Rubtsova, M. P., Sizova, D. V., Dmitriev, S. E., Ivanov, D. S., Prassolov, V. S., Shatsky, I. N.
(2003). Distinctive Properties of the 5'-Untranslated Region of Human Hsp70 mRNA. J. Biol. Chem.
278: 22350-22356
[Abstract]
[Full Text]
-
Tallet-Lopez, B., Aldaz-Carroll, L., Chabas, S., Dausse, E., Staedel, C., Toulme, J.-J.
(2003). Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res
31: 734-742
[Abstract]
[Full Text]
-
Lafuente, E., Ramos, R., Martinez-Salas, E.
(2002). Long-range RNA-RNA interactions between distant regions of the hepatitis C virus internal ribosome entry site element. J. Gen. Virol.
83: 1113-1121
[Abstract]
[Full Text]
-
Odreman-Macchioli, F., Baralle, F. E., Buratti, E.
(2001). Mutational Analysis of the Different Bulge Regions of Hepatitis C Virus Domain II and Their Influence on Internal Ribosome Entry Site Translational Ability. J. Biol. Chem.
276: 41648-41655
[Abstract]
[Full Text]
-
Hellen, C. U.T., Sarnow, P.
(2001). Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev.
15: 1593-1612
[Full Text]
-
Pestova, T. V., Kolupaeva, V. G., Lomakin, I. B., Pilipenko, E. V., Shatsky, I. N., Agol, V. I., Hellen, C. U. T.
(2001). Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. USA
98: 7029-7036
[Abstract]
[Full Text]
-
Martínez-Salas, E., Ramos, R., Lafuente, E., López de Quinto, S.
(2001). Functional interactions in internal translation initiation directed by viral and cellular IRES elements. J. Gen. Virol.
82: 973-984
[Full Text]